Table 7

Some newer strategies for an HIV vaccine

Replicating vectors, e.g. Adenoviruses 4 and 7, CMV, Sendai, VSV, alphavirus-VSV

DNA plasmids with electroporation

Non-parenteral routes of administration: intranasal, rectal, sublingual

DNA/NYVAC prime boost regimen

Gene-driven HIV antibody

Anti-phospholipid antibodies

Live, attenuated HIV, e.g. Δnef, Δnef/vpr, ΔGY

(Canarypox/gp prime-boost 120 trial still ongoing in Thailand)

Plotkin Journal of the International AIDS Society 2009 12:2   doi:10.1186/1758-2652-12-2